Stakeholders have the right to know whether the industry and patient representatives on the HTA Review reference committee objected to the declaration of interest, primarily because it invalidates the input of the people and organisations they claim to represent.
It's in the name - a stakeholder with an interest has a 'stake', not a conflict
February 22, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Guilt over this enduring failure is the correct response
September 9, 2026 - -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News -
'You can't fix a broken system by tinkering with parts of it'
September 9, 2026 - - Latest News -
A review recommendation that should be reconsidered because of time
September 8, 2026 - - Latest News -
The forgotten patients living in the long shadow of rare cancer
September 8, 2026 - - Latest News -
Pharmacists could save women millions and cut GP queues, new analysis shows
September 8, 2026 - - Latest News
